503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
35.66%
Net income growth at 50-75% of BB's 59.83%. Martin Whitman would worry about lagging competitiveness unless expansions are planned.
-4.48%
Negative yoy D&A while BB is 7.55%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-150.58%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
3.40%
SBC growth of 3.40% while BB is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
5.93%
Less working capital growth vs. BB's 113.91%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
-562.34%
Both yoy AR lines negative, with BB at -21.74%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-1143.75%
Negative yoy inventory while BB is 700.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
300.00%
AP growth well above BB's 103.10%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
47.16%
Growth well above BB's 54.76%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-7.95%
Both negative yoy, with BB at -825.00%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
3.24%
Operating cash flow growth below 50% of BB's 112.08%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-34.69%
Both yoy lines negative, with BB at -68.75%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
55.36%
Less M&A spending yoy vs. BB's 580.00%, reducing near-term risk. David Dodd would confirm the firm is not missing out on a strategic deal that competitor might exploit.
33.90%
Some yoy expansion while BB is negative at -38.28%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
-40.91%
Both yoy lines are negative, with BB at -13.66%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
90.46%
Less 'other investing' outflow yoy vs. BB's 637.50%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
-19.03%
Both yoy lines negative, with BB at -1783.33%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-1496.21%
We cut debt repayment yoy while BB is 100.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
23.46%
We slightly raise equity while BB is negative at -100.00%. John Neff sees competitor possibly preserving share count or buying back shares.
14.40%
Buyback growth of 14.40% while BB is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.